Reshaping what's possible in complex PCI with advanced sirolimus technology
Sponsored by Cordis
Stents, scaffolds and DCB
Symposium
Cordis
Room 242AB
Watch this session if you want
- To understand the value of minimising metal in complex PCI, and the role of drug biology and device design
- To discuss how DCB technologies differ in drug characteristics and biological effects, including pharmacokinetics, vessel healing, and lumen durability
- To apply practical decision-making for less‑metal PCI, including deliverability, dissection management, and patient and lesion selection
